Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Standard
Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. / Clausen, Peter; Ekbom, Pia; Damm, Peter; Feldt-Rasmussen, Ulla; Nielsen, Birthe; Mathiesen, Elisabeth R; Feldt-Rasmussen, Bo.
I: Journal of Diabetes and its Complications, Bind 21, Nr. 5, 2007, s. 288-93.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes
AU - Clausen, Peter
AU - Ekbom, Pia
AU - Damm, Peter
AU - Feldt-Rasmussen, Ulla
AU - Nielsen, Birthe
AU - Mathiesen, Elisabeth R
AU - Feldt-Rasmussen, Bo
PY - 2007
Y1 - 2007
N2 - Aim This study aims to test the hypothesis that vascular dysfunction is present early in pregnancy in women with type 1 diabetes who subsequently develop preeclampsia. Methods Eighty-three women with type 1 diabetes of more than 10 years duration were followed up prospectively during pregnancy. External ultrasound was used to measure the dilatory response of the brachial artery to postischemic increased blood flow (endothelium-dependent, flow-associated dilatation) and to nitroglycerin (NTG) [endothelium-independent, NTG-induced dilatation (NID)] at Gestational Weeks 11 and 29. Plasma concentrations of the vascular markers vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E-selectin, and von Willebrand factor antigen were also measured together with 24-h urinary albumin excretion (UAE), blood pressure (BP), and HbA1C. Results Fourteen (17%) of the 83 women developed preeclampsia. NID was significantly impaired at Week 29 in women prone to preeclampsia (108.8±7.0% vs. 116.8±8.9%, mean±S.D., P<.05), and the plasma concentrations of VCAM-1 and ICAM-1 were significantly elevated at Gestational Week 11 (612±82 vs. 516±109 µg/l, P<.005 and 293±67 vs. 255±57 µg/l, P<.05, respectively). Women who later developed preeclampsia were also characterized by higher UAE, higher BP, and higher HbA1C than women who did not [Gestational Week 11: 194 (3–1104) vs. 7 (0–412) mg/24 h, median (range), P=.0003; 122±12/75±6 vs. 111±11/69±9 mmHg, mean±S.D., P<.01; and 8.2% (5.9–10.5%) vs. 7.2% (5.3–10.9%), P=.008, respectively]. Conclusion This prospective study indicates that signs of maternal vascular dysfunction precede development of preeclampsia in women with type 1 diabetes.
AB - Aim This study aims to test the hypothesis that vascular dysfunction is present early in pregnancy in women with type 1 diabetes who subsequently develop preeclampsia. Methods Eighty-three women with type 1 diabetes of more than 10 years duration were followed up prospectively during pregnancy. External ultrasound was used to measure the dilatory response of the brachial artery to postischemic increased blood flow (endothelium-dependent, flow-associated dilatation) and to nitroglycerin (NTG) [endothelium-independent, NTG-induced dilatation (NID)] at Gestational Weeks 11 and 29. Plasma concentrations of the vascular markers vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E-selectin, and von Willebrand factor antigen were also measured together with 24-h urinary albumin excretion (UAE), blood pressure (BP), and HbA1C. Results Fourteen (17%) of the 83 women developed preeclampsia. NID was significantly impaired at Week 29 in women prone to preeclampsia (108.8±7.0% vs. 116.8±8.9%, mean±S.D., P<.05), and the plasma concentrations of VCAM-1 and ICAM-1 were significantly elevated at Gestational Week 11 (612±82 vs. 516±109 µg/l, P<.005 and 293±67 vs. 255±57 µg/l, P<.05, respectively). Women who later developed preeclampsia were also characterized by higher UAE, higher BP, and higher HbA1C than women who did not [Gestational Week 11: 194 (3–1104) vs. 7 (0–412) mg/24 h, median (range), P=.0003; 122±12/75±6 vs. 111±11/69±9 mmHg, mean±S.D., P<.01; and 8.2% (5.9–10.5%) vs. 7.2% (5.3–10.9%), P=.008, respectively]. Conclusion This prospective study indicates that signs of maternal vascular dysfunction precede development of preeclampsia in women with type 1 diabetes.
U2 - 10.1016/j.jdiacomp.2006.03.004
DO - 10.1016/j.jdiacomp.2006.03.004
M3 - Journal article
C2 - 17825752
VL - 21
SP - 288
EP - 293
JO - Journal of Diabetes and its Complications
JF - Journal of Diabetes and its Complications
SN - 1056-8727
IS - 5
ER -
ID: 34076330